{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:44:43Z","timestamp":1770975883104,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":302,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.rmcr.2025.102321","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:18:17Z","timestamp":1761959897000},"page":"102321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Case report: Successful use of sotatercept to treat pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia"],"prefix":"10.1016","volume":"58","author":[{"given":"Abinaya","family":"Ramakrishnan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Olitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajan","family":"Saggar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard N.","family":"Channick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8027-0112","authenticated-orcid":false,"given":"Justin P.","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rmcr.2025.102321_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.crad.2016.12.002","article-title":"Follow-up interval for small untreated pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia","volume":"72","author":"Ryan","year":"2017","journal-title":"Clin. Radiol."},{"issue":"5","key":"10.1016\/j.rmcr.2025.102321_bib2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2036.2008.03775.x","article-title":"Review article: the hepatic manifestations of hereditary haemorrhagic telangiectasia","volume":"28","author":"Sabba","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.rmcr.2025.102321_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2796.2005.01555.x","article-title":"Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia","volume":"258","author":"Kjeldsen","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.rmcr.2025.102321_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000458447","article-title":"Pulmonary hypertension in a large cohort with hereditary hemorrhagic telangiectasia","volume":"94","author":"Vorselaars","year":"2017","journal-title":"Respiration"},{"key":"10.1016\/j.rmcr.2025.102321_bib5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1164\/rccm.201702-0267LE","article-title":"Pulmonary hypertension prevalence and prognosis in a cohort of patients with hereditary hemorrhagic telangiectasia undergoing embolization of pulmonary arteriovenous malformations","volume":"196","author":"Chizinga","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmcr.2025.102321_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00380-010-0079-z","article-title":"Successful bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia","volume":"26","author":"Chang","year":"2011","journal-title":"Heart Vessel."},{"issue":"Suppl 3","key":"10.1016\/j.rmcr.2025.102321_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2362.2006.01683.x","article-title":"Bosentan therapy for pulmonary arterial hypertension associated with hereditary haemorrhagic telangiectasia","volume":"36","author":"Bonderman","year":"2006","journal-title":"Eur. J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.rmcr.2025.102321_bib8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/adc.2007.133082","article-title":"Clinical features of pulmonary arterial hypertension in young people with an ALK1 mutation and hereditary haemorrhagic telangiectasia","volume":"94","author":"Smoot","year":"2009","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.rmcr.2025.102321_bib9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijcard.2016.03.211","article-title":"Pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia successfully treated with sildenafil","volume":"214","author":"Miyake","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.rmcr.2025.102321_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13256-022-03296-9","article-title":"Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report","volume":"16","author":"Walsh","year":"2022","journal-title":"J. Med. Case Rep."},{"issue":"4","key":"10.1016\/j.rmcr.2025.102321_bib11","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1378\/chest.06-2275","article-title":"Long-term outcome in a patient with pulmonary hypertension and hereditary hemorrhagic telangiectasia","volume":"131","author":"Minai","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.rmcr.2025.102321_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102033","article-title":"Treatment of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia\u2014a case series and systematic review","volume":"68","author":"Abston","year":"2021","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.rmcr.2025.102321_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003896","article-title":"Clinical adverse effects of endothelin receptor antagonists: insights from the meta-analysis of 4894 patients from 24 randomized double-blind placebo-controlled clinical trials","volume":"5","author":"Wei","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.rmcr.2025.102321_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/2045893217719250","article-title":"Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension","volume":"7","author":"Kingman","year":"2017","journal-title":"Pulm. Circ."},{"issue":"1","key":"10.1016\/j.rmcr.2025.102321_bib15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCULATIONAHA.110.944603","article-title":"Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension","volume":"122","author":"Schwartz","year":"2010","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.rmcr.2025.102321_bib16","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.rmcr.2025.102321_bib17","first-page":"1201","article-title":"Phase 2 PULSAR trial of sotatercept for the treatment of pulmonary arterial hypertension","volume":"384","author":"Hoeper","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.rmcr.2025.102321_bib18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lary.20818","article-title":"An epistaxis severity score for hereditary hemorrhagic telangiectasia","volume":"120","author":"Hoag","year":"2010","journal-title":"Laryngoscope"},{"issue":"1 Suppl","key":"10.1016\/j.rmcr.2025.102321_bib19","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jacc.2009.04.015","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"54","author":"Machado","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.rmcr.2025.102321_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/jmg.40.12.865","article-title":"Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia","volume":"40","author":"Harrison","year":"2003","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.rmcr.2025.102321_bib21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/bjh.12838","article-title":"An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin","volume":"165","author":"Carrancio","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.rmcr.2025.102321_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3324\/haematol.2018.198887","article-title":"Sotatercept, a novel transforming growth factor \u03b2 ligand trap, improves anemia in \u03b2-thalassemia: a phase II, open-label, dose-finding study","volume":"104","author":"Cappellini","year":"2019","journal-title":"Haematologica"}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125001571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007125001571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:42:17Z","timestamp":1770972137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007125001571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":22,"alternative-id":["S2213007125001571"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102321","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case report: Successful use of sotatercept to treat pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2025.102321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102321"}}